We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Medtronic
MDT
$107B
| $143M | 0.31% |
1,765,700
+163,062
| +10% | +$14.7M |
|
52
Netflix
NFLX
$292B
| $140M | 0.31% |
5,949,650
+847,820
| +17% | +$18.8M |
|
53
Tesla
TSLA
$1.24T
| $140M | 0.31% |
527,417
-815,431
| -61% | -$228M |
|
54
CrowdStrike
CRWD
$187B
| $140M | 0.31% |
3,392,636
-1,860,028
| -35% | -$85.1M |
|
55
Alphabet (Google) Class C
GOOG
$3.9T
| $139M | 0.31% |
1,449,977
-195,223
| -12% | -$21.8M |
|
56
MongoDB
MDB
$24B
| $138M | 0.3% |
696,998
+325,136
| +87% | +$94.9M |
|
57
Baxter International
BAX
$11.6B
| $137M | 0.3% |
2,552,278
+2,525,732
| +9,515% | +$152M |
|
58
Fortive
FTV
$19B
| $137M | 0.3% |
3,112,257
+1,336,777
| +75% | +$62.5M |
|
59
Walmart Inc
WMT
$871B
| $136M | 0.3% |
3,155,895
+3,029,898
| +2,405% | +$133M |
|
60
Alcon
ALC
$33.1B
| $130M | 0.29% |
2,208,062
-375,044
| -15% | -$26M |
|
61
TransUnion
TRU
$14.8B
| $130M | 0.28% |
2,182,146
+290,223
| +15% | +$22.3M |
|
|
SKX
62
DELISTED
Skechers
SKX
| $130M | 0.28% |
4,091,278
-386,116
| -9% | -$14.5M |
|
63
Eli Lilly
LLY
$1.07T
| $129M | 0.28% |
400,245
-733,148
| -65% | -$232M |
|
64
Vulcan Materials
VMC
$36.3B
| $128M | 0.28% |
811,956
-389,690
| -32% | -$63.3M |
|
65
International Flavors & Fragrances
IFF
$19.4B
| $126M | 0.28% |
1,390,201
+207,196
| +18% | +$23.7M |
|
66
Meta Platforms (Facebook)
META
$1.51T
| $126M | 0.28% |
927,903
-64,620
| -7% | -$10.5M |
|
67
Union Pacific
UNP
$183B
| $125M | 0.27% |
639,443
-675,694
| -51% | -$150M |
|
68
JD.com
JD
$40.8B
| $124M | 0.27% |
2,463,812
+2,024,813
| +461% | +$120M |
|
69
PUT
Lockheed Martin
LMT
$134B
| $119M | 0.26% |
+307,500
| New | +$128M |
|
70
Airbnb
ABNB
$83.7B
| $119M | 0.26% |
1,130,609
-2,022,017
| -64% | -$224M |
|
71
Crocs
CROX
$6.69B
| $118M | 0.26% |
1,717,628
+1,283,455
| +296% | +$89.1M |
|
72
Verizon
VZ
$194B
| $117M | 0.26% |
3,075,841
+2,859,054
| +1,319% | +$127M |
|
73
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $115M | 0.25% |
1,449,400
+1,428,800
| +6,936% | +$120M |
|
74
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $115M | 0.25% |
321,900
-373,900
| -54% | -$148M |
|
|
75
CALL
Lockheed Martin
LMT
$134B
| $115M | 0.25% |
+297,500
| New | +$124M |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.